Comprehensive Brain Malformation Panel
Use
This test is designed for individuals exhibiting attributes or having a clinical or potential diagnosis of brain malformation disorders. It is also applicable for those with abnormal brain imaging detected via MRI, CT scans, or ultrasonography, as well as individuals with early-presenting brain malformation symptoms occurring before or at birth, and those with a family history of brain malformations.
Special Instructions
Tests were developed and validated by PreventionGenetics LLC following CAP and CLIA regulations. Not cleared or approved by the FDA.
Limitations
The test results must be interpreted with consideration of the provided clinical information and family history. These tests have not been cleared or approved by the US Food and Drug Administration, which may limit certain clinical applications.
New York Approved
Methodology
NGS
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided